Category Archives: Gadolinium

Featured Stories

FDA Advisors Set to Examine Metal-on-Metal Hip Implant Safety Concerns

Thousands of people with metal-on-metal hip implant devices could soon get some answers from the U.S. Food & Drug Administration (FDA) about the dangers they face. Tomorrow, the agency will convene a panel of outside medical experts to examine the safety record of metal-on-metal hip replacements, and recommend the ...

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

DePuy ASR Hip Implants, Other Faulty Medical Devices Subject to Little FDA Oversight, Investigation Finds

A newly-published investigation from ProPublica has revealed that several questionable types of medical devices, including DePuy Orthopaedic’s recalled ASR hip implant, managed to make it to market without much scrutiny on the part of the U.S. Food & Drug Administration (FDA).

Read More

FDA Urged to Ban Powdered Caffeine

FDA Urged to Ban Powdered Caffeine

Pennsylvania Senator Robert Casey has written to the Food and Drug Administration (FDA) to urge the agency to ban powdered caffeine, a dietary supplement.

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

DeflateGate’s Effects Impact Legal Gambling & the Economy

DeflateGate’s-Effects-Impact-Legal-Gambling-and-the-Economy

The NFL has initiated a probe into the New England Patriots following allegations that the team intentionally used overly deflated footballs.

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Study Suggests Hormonal Contraceptives Linked to Brain Tumor

Study Suggests Hormonal Contraceptives Linked to Increased Brain Tumor Risk

A study of Danish women of reproductive age suggests that long-term use of hormonal contraceptives is associated with an increased risk of brain tumors.

Read More

Omniscan NSF Lawsuit Settled

What would have been the first < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan lawsuit to go to a jury trial was settled at the last minute. The terms of the settlement are confidential, according to a report on ProPublica. Omniscan is gadolinium contrast dye that … Continue reading

Posted in Gadolinium, Pharmaceuticals |

First Omniscan Jury Trial Starts Today

The first jury trial involving General Electric’s < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye is scheduled to begin today. The plaintiff in the lawsuit, an elderly Minnesota woman, claims she developed nephrogenic systemic fibrosis (NSF) after being injected with Omniscan as part … Continue reading

Posted in Gadolinium, Pharmaceuticals |

Fewer Kidney Patients Received Gadolinium Agents Following 2006 NSF Alert

Fewer kidney patients have received < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dyes during MR studies since the US Food & Drug Administration (FDA) first issued warnings about their association with nephrogenic systemic fibrosis (NSF) in 2006. NSF is a condition involving the formation … Continue reading

Posted in Gadolinium, Pharmaceuticals |

FDA Strengthens Warnings on Gadolinium MRI Dyes

Gadolinium-based contrast dyes will now bear new warnings on their labels regarding their association with nephrogenic systemic fibrosis (NSF), according to the Food & Drug Administration (FDA). Gadolinium-based contrast dyes are intravenous drugs approved by the FDA for use with … Continue reading

Posted in Gadolinium, Pharmaceuticals |

Dutch Regulators Fault GE for Failing to Report Omniscan NSF Case

The Danish Medicines Agency has charged that GE Healthcare violated Dutch law when it failed to promptly and completely inform regulators about a patient who died after developing nephrogenic systemic fibrosis (NSF) following exposure to < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan contrast dye. According … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Healthcare Advised to Restrict Omniscan in 2006

GE Healthcare’s own experts recommended in May 2006 that it proactively restrict the use of < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan, a gadolinium contrast dye, after it was linked to nephrogenic systemic fibrosis (NSF). According to a ProPublica investigation, rather than take that advice, … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Drops Omniscan Libel Suit

GE Healthcare has dropped a libel suit it filed in the United Kingdom (UK) against a Danish researcher who had who warned its < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye was associated with nephrogenic systemic fibrosis (NSF) in 2007. When GE Healthcare sued … Continue reading

Posted in Gadolinium, Pharmaceuticals |

GE Using UK Libel Laws to Shield Omniscan from Criticism, Doctor Claims

General Electric has been accused of trying to stifle criticism of its < "http://www.yourlawyer.com/topics/overview/omniscan_gadolinium">Omniscan gadolinium contrast dye by a Danish radiologist who warned it was associated with nephrogenic systemic fibrosis (NSF) in 2007. According to an article in The Guardian, … Continue reading

Posted in Gadolinium, Pharmaceuticals |

FDA Should Tighten Restrictions on Omniscan, OptiMark, Panel Says

A panel of medical experts reviewing gadolinium contrast dyes recommended last week that the labeling for General Electric’s Omniscan and Covidien’s OptiMark should have stronger warnings regarding their risk of < "http://www.yourlawyer.com/topics/overview/nsf">nephrogenic systemic fibrosis (NSF). According to an article on … Continue reading

Posted in Gadolinium, Pharmaceuticals |

First NSF Lawsuit to Go to Trial in California

One of the first trials involving a < "http://www.yourlawyer.com/topics/overview/gadolinium">gadolinium contrast dye – Magnevist – and nephrogenic systemic fibrosis (NSF) is set to begin in January. According to a report on Law.com, the outcome of the Magnevist trial could be a … Continue reading

Posted in Gadolinium, Pharmaceuticals |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.